Confirm your location

Confirm you location or select from a list of countries in order to get in touch with your local Ottobock market. We will make sure you´re redirected to your selected site in the future so you´ll always be in the right place.

News December 2023

Innovative concepts for neuromobility care: How might patients benefit?

A growing number of assistive products are becoming available for people with neurological conditions. Some of these innovative technologies are already generating compelling levels of evidence to support their value, both individually and in combination. In Ottobock’s latest virtual webinar, three experts presented recent findings for two promising clinical applications: early rehabilitation of individuals with spinal cord injury (SCI) using a microprocessor-controlled stance- and swing-phase knee-ankle-foot orthosis (C-Brace®) and management of spastic movement disorder with the latest version of the Exopulse Mollii Suit.

Dr. Hahn opened the discussion with the results of an exploratory trial of the Exopulse Mollii Suit: a near-full-body neurostimulation garment designed to reduce spasticity and related pain with just an hour of wear time. New clinical evidence now shows that this approach can deliver swift, significant, and sustained improvement in both patients’ mobility and pain levels.

More about the clinical evidence for Exopulse Mollii Suit »

Joining virtually from his clinic in Chicago, Dr. Arun Jayaraman, PT, shared his experience comparing novel and traditional approaches to functional rehabilitation of patients with both complete and incomplete SCI. Dr. Jayaraman and his team recently conducted a study to evaluate post-inpatient rehabilitation outcomes achieved using two different approaches.

More about SCI. Dr. Jayaraman's study »

Looking ahead: New innovations may offer life-changing opportunities

In closing the symposium, Dr. Greitemann noted that each of these three datasets offers compelling support for the use of technologies like C-Brace and the Exopulse Mollii Suit – but that now is the time for clinicians to focus closely on identifying patients with the greatest possibility to benefit from either or both devices. With a combination of convincing evidence and clear selection criteria, these novel technologies may have the potential to make a transformative impact in neuromobility outcomes.

To view the recording of the webinar, please register by clicking on this link. After successful registration, the link to the recording will be sent in the confirmation email.

Multiple sclerosis patient before and after wearing the Exopulse Mollii Suit
News | Dec 2023

New clinical evidence on the Exopulse Mollii Suit